<code id='92BCFDBD5B'></code><style id='92BCFDBD5B'></style>
    • <acronym id='92BCFDBD5B'></acronym>
      <center id='92BCFDBD5B'><center id='92BCFDBD5B'><tfoot id='92BCFDBD5B'></tfoot></center><abbr id='92BCFDBD5B'><dir id='92BCFDBD5B'><tfoot id='92BCFDBD5B'></tfoot><noframes id='92BCFDBD5B'>

    • <optgroup id='92BCFDBD5B'><strike id='92BCFDBD5B'><sup id='92BCFDBD5B'></sup></strike><code id='92BCFDBD5B'></code></optgroup>
        1. <b id='92BCFDBD5B'><label id='92BCFDBD5B'><select id='92BCFDBD5B'><dt id='92BCFDBD5B'><span id='92BCFDBD5B'></span></dt></select></label></b><u id='92BCFDBD5B'></u>
          <i id='92BCFDBD5B'><strike id='92BCFDBD5B'><tt id='92BCFDBD5B'><pre id='92BCFDBD5B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:9
          Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT
          Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

          WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

          The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

          advertisement

          The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Study: Spinal cord stimulation helps patients with paralysis walk again
          Study: Spinal cord stimulation helps patients with paralysis walk again

          GrégoireCourtineadvisesDavid,apatient.Courtine’slatestresearchpapersuggestspersonalizedelectricalsti

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          PBMs are inflating the cost of generic drugs. They must be reined in

          AdobeThesearenotcomfortabledaysinWashingtonforpharmacybenefitmanagers,thehighlyconsolidatedgroupofin